Empresa Deciphera Pharmaceuticals, Inc.
Acciones
DCPH
US24344T1016
Biotecnología e investigación médica
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
25,34 USD | +0,26 % | +73,60 % | +57,35 % |
30/04 | DECIPHERA PHARMACEUTICALS, INC. : Leerink Partners da una recomendación neutral | ZM |
30/04 | DECIPHERA PHARMACEUTICALS, INC. : Actualizado a Neutral por JMP Securities | ZM |
Resumen de negocios
Número de empleados: 355
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Switch Control Kinase Inhibitor Platform
100,0
%
| 126 | 100,0 % | 159 | 100,0 % | +26,75 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
76,4
%
| 97 | 77,5 % | 122 | 76,4 % | +25,03 % |
Rest of World
12,3
%
| 14 | 11,1 % | 20 | 12,3 % | +39,91 % |
Germany
11,3
%
| 14 | 11,4 % | 18 | 11,3 % | +25,58 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17/05/18 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 01/02/15 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Chief Tech/Sci/R&D Officer | - | 01/01/17 | |
Dashyant Dhanak
CTO | Chief Tech/Sci/R&D Officer | 63 | 05/09/23 |
Matthew Sherman
CTO | Chief Tech/Sci/R&D Officer | 68 | 02/10/19 |
Lisa Amaya Price
HRO | Human Resources Officer | - | 01/01/22 |
Kelley Dealhoy
PRN | Corporate Officer/Principal | - | 16/06/22 |
Jama Pitman
PRN | Corporate Officer/Principal | 45 | 01/01/15 |
Daniel Martin
PRN | Corporate Officer/Principal | 49 | 18/09/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Patricia Allen
BRD | Director/Board Member | 62 | 01/09/16 |
Edward Benz
BRD | Director/Board Member | 78 | 01/07/19 |
Ron Squarer
CHM | Chairman | 57 | 04/12/19 |
John R. Martin
BRD | Director/Board Member | 63 | 01/02/15 |
James Bristol
BRD | Director/Board Member | 77 | 01/08/07 |
Susan Kelley
BRD | Director/Board Member | 69 | 08/07/19 |
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17/05/18 |
Dennis Walsh
BRD | Director/Board Member | 56 | 01/02/15 |
Director/Board Member | 66 | 01/11/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 82 225 972 | 57 541 331 ( 69,98 %) | 0 | 69,98 % |
Información de la empresa
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+57,35 % | 2077,85 M | |
-1,79 % | 102 mil M | |
+2,33 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-16,93 % | 21,4 mil M | |
-8,79 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-13,80 % | 16,09 mil M | |
+5,01 % | 13,83 mil M | |
+33,02 % | 11,97 mil M |
- Bolsa de valores
- Acciones
- Acción DCPH
- Empresa Deciphera Pharmaceuticals, Inc.